Student Seminars and Defenses
NSC 503 Seminar
Adam Roszczyk & Caleb Mahlen - PhD Candidates
Titles: TBD
Faculty Evaluators: Manoela Fogaca & Andrew Wojtovich
Student Moderator: Tanique McDonald
Apr 07, 2025 @ 4:00 p.m.
Medical Center | K307
Astrocytic Mitochondrial Oxidative Stress Effect on Tau Pathology Using Chemogenetics - Thesis Proposal
Dominic Bunn - PhD Candidate, Neuroscience Graduate Program
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of tau and amyloid beta aggregates, reactive astrocytes, activated microglia, and oxidative stress. Tau aggregation is considered a primary driver of the disease, with systematic propagation of tau pathology through the brain in Braak stages. Astrocytes are known to uptake tau, but whether this is beneficial or detrimental is still debated. Mitochondrial reactive oxygen species (ROS) production is one regulator of astrocyte function, as their mitochondria are known to generate an increased amount of ROS compared to other cell types. This mitochondrial ROS production is utilized for signaling that regulates many astrocytic functions. Despite oxidative stress being an early hallmark of AD that has been extensively studied, the specific relationship between astrocytic ROS and tau pathology is unknown. Interestingly, exposure to pathological tau induces mitochondrial dysfunction in astrocytes. Neonatal astrocytes from tauopathy models also adopt abnormal phenotypes, with increased reactivity markers and reduced neurosupportive functions. While no studies have looked at the impact of mitochondrial ROS on astrocytic tau uptake specifically, astrocytic upregulation of BAG3 and transcription factor EB have been shown to increase uptake and have neuroprotective effects in AD. Both proteins are suggested to be regulated by Nrf2 activity, which responds to oxidative stress. These studies suggest mitochondrial ROS is an important regulator of astrocyte function within AD, but the specific relationship has never been directly explored. We hypothesize that increased mitochondrial ROS production will increase tau uptake but impair the ability of the astrocytes to degrade uptaken tau and reduce their neuroprotective functions. To test this hypothesis, we propose to use in vitro approaches that allow for spatially and temporally controlled ROS production. We will generate ROS within the mitochondria of AD model-derived astrocytes. The AD model used is the PS19 mouse model, which expresses human tau with the P301S mutation, known to cause tau pathology in humans, under the mouse prion promoter. While significant tau aggregate pathology is not observed until 6 months in the PS19 model, the prion promoter is active shortly after neurons differentiate. In Aim 1, we will utilize chemogenetics to generate mitochondrial ROS, alongside the ROS biosensor HyPer7, to assess the impact of mitochondrial ROS production on astrocyte mitochondrial health, and neurosupportive functions. The goal of this aim is to understand basal differences in ROS production, ROS sensitivity, and mitochondrial function between PS19 and wild type astrocytes In Aim 2, we will utilize chemogenetic approaches of generating mitochondrial ROS to investigate the effect of ROS on the uptake, degradation, and propagation of tau pathology. The chemogenetic control of ROS production allows for the spatial and temporal control of ROS production independent of metabolism, allowing us to test the cause and effect relationship of ROS generation and tau processing. The experiments proposed are achievable within the lab and will advance our understanding of astrocyte function and oxidative stress in the context of AD.
Apr 10, 2025 @ 11:00 a.m.
Medical Center | 2-7534
NSC 503 Seminar
Tracey Preko & Skylar DeWitt - PhD Candidates
Titles: TBD
Faculty Evaluators: Samuel Norman-Haignere & Ania Busza
Student Moderator: Amelia Hines
Apr 14, 2025 @ 4:00 p.m.
Medical Center | K307
NSC 503 Seminar
Wen Li & Yunshan Cai - PhD Candidates
Titles: TBD
Faculty Evaluators: Rick Libby & Ed Brown
Student Moderator: Mariah Marrero
Apr 21, 2025 @ 4:00 p.m.
Medical Center | K307
NSC 503 Seminar
Joanne Chiu & Emma Bryson - PhD Candidates
Titles: TBD
Faculty Evaluators: Jean Bidlack & David Dodell-Feder
Student Moderator: Daulton Myers
Apr 28, 2025 @ 4:00 p.m.
Medical Center | K307
NSC 503 Seminar
Alesandra Martin & Emma Strawderman - PhD Candidates
Titles: TBD
Faculty Evaluators: Michael Telias & Frank Garcea
Student Moderator: Jeeyun Kim
May 05, 2025 @ 4:00 p.m.
Medical Center | K207
NSC 503 Seminar
Alex Solorzano & Alexis Feidl - PhD Candidates
Titles: TBD
Faculty Evaluators: John Olschowka & Debroah Cory-Slechta
Student Moderator: Margaux Masten
May 12, 2025 @ 4:00 p.m.
Medical Center | K207
NSC 503 Seminar
Catalina Guzman - PhD Candidate
Title: TBD
Faculty Evaluators: Ania Majewska & Loisa Bennetto
Student Moderator: Gavin Magill
May 19, 2025 @ 4:00 p.m.
Medical Center | K207